Abstract:Background: Zeaxanthin is a natural xanthophyll carotenoid that is widely produced by plants, algae and microorganisms and plays a critical role in the prevention of age-related eye diseases, such as macular degeneration and cataracts. Zeaxanthin is also used in the food, pharmaceutical and nutraceutical industries because of its strong antioxidant and anti-cancer properties. To date, zeaxanthin has been primarily produced by extraction from natural resources, especially plants, which is costly and environmentally unfriendly. The biosynthesis of zeaxanthin by microorganisms has been reported in lots of works to provide another potential route for zeaxanthin production. Scope and approach: In this review, we discuss the zeaxanthin biosynthetic pathway, naturally occurring zeaxanthin-accumulating, microorganisms containing bacteria and microalgae, the optimization of fermentation conditions using these microorganisms, and zeaxanthin production using microbial cells factory constructed by metabolic engineering. The different metabolic engineering strategies and the zeaxanthin-accumulating level of the reviewed wild and engineered microorganisms are also considered. Furthermore, this work presents perspectives concerning the microbial production of zeaxanthin, especially the trends to construct the metabolically engineered microorganisms for zeaxanthin production. Key findings and conclusions: To date, all the reported wild zeaxanthin-accumulating microorganisms belong to either bacteria or microalgae, while most of the reported engineering microorganisms for zeaxanthin production are Escherichia coli or yeast. A feasible strategy for zeaxanthin production is the use of metabolic engineering to construct a zeaxanthin-accumulating microbial cells factories followed by the optimization of fermentation with the engineered strain. Besides the simple overexpression of the biosynthesizing genes, the dynamic regulation of the constructed pathway has also been used for zeaxanthin production by metabolic engineering. Construction of better microbial cells factories which produce more zeaxanthin will profit from the breakthrough of the following fields: Introduction of higher plant zeaxanthin biosynthesizing genes into microorganisms; Characterization of novel zeaxanthin pathway genes from the wild microorganisms producing high level of zeaxanthin; Deep investigation of the farnesyl diphosphate formation pathway; Construction of microbial host with weak antioxidative capacity.

Metabolic engineering of Escherichia coli for de novo production of betaxanthins.

Alleviation of metabolic bottleneck by combinatorial engineering enhanced astaxanthin synthesis in Saccharomyces cerevisiae.

Metabolic Engineering of Escherichia Coli to Produce Zeaxanthin

Biotechnological Production of Astaxanthin Through Metabolic Engineering of Yeasts

Engineering CrtW and CrtZ for improving biosynthesis of astaxanthin in Escherichia coli

Improvement of Betanin Biosynthesis in Saccharomyces Cerevisiae by Metabolic Engineering

Engineering of β -carotene hydroxylase and ketolase for astaxanthin overproduction in Saccharomyces cerevisiae

Metabolic Engineering Of Escherichia Coli For Producing Astaxanthin As The Predominant Carotenoid

Genome mining of astaxanthin biosynthetic genes from Sphingomonas sp. ATCC 55669 for heterologous overproduction in Escherichia coli

Metabolic engineering of Escherichia coli for high-level production of violaxanthin

Construction of Canthaxanthin-Producing Yeast by Combining Spatiotemporal Regulation and Pleiotropic Drug Resistance Engineering

Cell-Free Production of Pentacyclic Triterpenoid Compound Betulinic Acid from Betulin by the Engineered Saccharomyces cerevisiae.

Highly efficient biosynthesis of astaxanthin in Saccharomyces cerevisiae by integration and tuning of algal crtZ and bkt

Combinatorial Expression of Different Β-Carotene Hydroxylases and Ketolases in Escherichia Coli for Increased Astaxanthin Production.

Enhancing Β-Carotene Production in Escherichia Coli by Perturbing Central Carbon Metabolism and Improving the NADPH Supply.

[Construction and optimization of ergothioneine-producing Escherichia coli]

Metabolic engineering synthesis of neoxanthin, a key precursor of fucoxanthin

Enzyme and Pathway Engineering for Improved Betanin Production in Saccharomyces cerevisiae

Astaxanthin Overproduction in Yeast by Strain Engineering and New Gene Target Uncovering

Biotechnological Production of Zeaxanthin by Microorganisms

Tailoring Cyanobacteria As a New Platform for Highly Efficient Synthesis of Astaxanthin.